Next-generation-sequencing-articles-open-access
Next Generation Sequence (NGS), also known as high throughput sequence, is the term 'occupied' which is used to describe a number of different modern
sequencing technologies. These technologies allow DNA and RNA
sequencing to be much faster and cheaper than Sanger's previously used sequence, and as such revolutionized
genomics and molecular biology. Such technologies include: Illumina Sequence (Solexa) Sequence, Roche Sequence 454, Ion Sequence: Proton Sequence / PGM.NGS Significantly cheaper, faster, require significantly less DNA and is more accurate and reliable than Sanger Sequence. NGS faster than Sanger sequence. Reduced time, manpower and regents at NGS mean that the costs are much lower. Repeats are intrinsic to NGS, as each reading is increased before sequencing, and because it relies on many overlapping short reads, so each section of DNA or RNA is composed several times.
High Impact List of Articles
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
HER2/neu: an increasingly important therapeutic target. Part 3: clinical applications and investigations
Edward L Nelson
Clinical Trail Outcomes: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
Assessing health-related quality of life in cancer trials
Roxanne E Jensen, Carol M Moinpour, Diane L Fairclough
Clinical Trail Perspective: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
IL-17 in systemic lupus erythematosus
Wu Qian, Antonio La Cava
Review: Clinical Trail Outcomes: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
-
BRAF-targeted therapy for metastatic melanoma: rationale, clinical activity and safety
Rahat Noor, Van A Trinh, Kevin B Kim, Wen-Jen Hwu
Review Article: Clinical Investigation
Relevant Topics in Clinical